Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remuzzi

Showing results (251-260 of 546) with videos related to

Pageof 55
Sort By:
Journal of Clinical Pathology|July 1, 1980
Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patientsF Pusineri, A Bini, L Mussoni, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1993
Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the diseaseP Ruggenenti, M Galbusera, R P Cornejo, et al.
The International Journal of Artificial Organs|February 26, 2009
Thrice-weekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapyP Cravedi, P Ruggenenti, G Mingardi, et al.
Lancet (London, England)|April 4, 1992
Urinary excretion of platelet-activating factor in haemolytic uraemic syndromeA Benigni, P Boccardo, M Noris, et al.
Experimental Nephrology|July 1, 1994
Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damageN Perico, C S Amuchastegui, B Malanchini, et al.
The Journal of Clinical Investigation|October 3, 2001
Challenges to achieving clinical transplantation toleranceA D Salama, G Remuzzi, W E Harmon, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1996
A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicityA Perna, E Gotti, E de Bernardis, et al.
Nephron|January 1, 1978
Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysisG Remuzzi, M Livio, G Marchiaro, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1997
Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administrationF Gaspari, M F Anedda, O Signorini, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1979
Platelet hypersensitivity in the nephrotic syndromeG Remuzzi, D Marchesi, G Mecca, et al.
Pageof 55

Showing results (251-260 of 546) with videos related to

Sort By:
Pageof 55
Journal of Clinical Pathology|July 1, 1980
Intermittent heparin treatment does not induce hypercoagulability in haemodialysed patientsF Pusineri, A Bini, L Mussoni, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1993
Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the diseaseP Ruggenenti, M Galbusera, R P Cornejo, et al.
The International Journal of Artificial Organs|February 26, 2009
Thrice-weekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapyP Cravedi, P Ruggenenti, G Mingardi, et al.
Lancet (London, England)|April 4, 1992
Urinary excretion of platelet-activating factor in haemolytic uraemic syndromeA Benigni, P Boccardo, M Noris, et al.
Experimental Nephrology|July 1, 1994
Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damageN Perico, C S Amuchastegui, B Malanchini, et al.
The Journal of Clinical Investigation|October 3, 2001
Challenges to achieving clinical transplantation toleranceA D Salama, G Remuzzi, W E Harmon, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1996
A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicityA Perna, E Gotti, E de Bernardis, et al.
Nephron|January 1, 1978
Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysisG Remuzzi, M Livio, G Marchiaro, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1997
Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administrationF Gaspari, M F Anedda, O Signorini, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1979
Platelet hypersensitivity in the nephrotic syndromeG Remuzzi, D Marchesi, G Mecca, et al.
Pageof 55